This page shows you your search results in order of date.
Order by Relevance | Date
Total 26238 results found since Jan 2013.
Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancer
To outline the toxicity, tolerability, and efficacy of a 3D conformal computed tomography planned endoluminal brachytherapy (ELBT) treatment for esophageal adenocarcinoma (OAC) or squamous cell carcinoma (OSCC).
Source: Brachytherapy - September 22, 2023 Category: Cancer & Oncology Authors: Christopher M. Jones, Annabel Lyles, Peter Bownes, Rebecca Goody, Mohan Hingorani, Eldho Joseph, Ganesh Radhakrishna Source Type: research
A scintillation dosimeter with real-time positional tracking information for in vivo dosimetry error detection in HDR brachytherapy
CONCLUSIONS: This work demonstrates that integrating EM tracking to in vivo scintillation dosimeters enables the detection of smaller shifts, by decreasing the dosimeter positioning uncertainty. It also serves to perform position-dependent energy correction for the inorganic scintillator,providing better SNR and SBR, allowing detection of errors at greater distances from the source.PMID:37731203 | DOI:10.1002/acm2.14150
Source: Journal of Applied Clinical Medical Physics - September 21, 2023 Category: Physics Authors: Daline Tho Marie-Claude Lavall ée Luc Beaulieu Source Type: research
Cancers, Vol. 15, Pages 4647: Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution
This study retrospectively evaluates clinical outcomes of dose escalation to involved nodes using volumetric modulated arc therapy (VMAT) with simultaneous integrated boost (SIB) for node-positive locally advanced cervical cancer (LACC) at a single institution. Consecutive patients with node-positive LACC (FIGO2018 IIIC1-IVA) who received definitive chemoradiotherapy by VMAT 45 Gy in 25 fractions with SIB to 55–57.5 Gy, followed by magnetic resonance image-guided adaptive brachytherapy (IGABT) between 2018 and 2022 were identified. A standardized strategy regarding nodal boost delivery and elective para-aorti...
Source: Cancers - September 20, 2023 Category: Cancer & Oncology Authors: Elki Sze-Nga Cheung Frederick Chun-Him Law Nelson Tsz-Cheong Fung Inda Sung Soong Rico Hing-Ming Hung Teddy Ka-Ho Tse Ken Ka-Shing Wong Philip Yuguang Wu Tags: Article Source Type: research
Comparison of intraluminal brachytherapy combined with and without stent placement for treatment of obstructive jaundice induced by tumor thrombus
To compare the safety and efficacy of intraluminal brachytherapy with iodine-125 (125I) seed strand implantation combined with and without stent placement to treat patients with obstructive jaundice induced by tumor thrombus.
Source: Brachytherapy - September 19, 2023 Category: Cancer & Oncology Authors: HuiYi Sun, MinJie Yang, FeiHang Wang, DanYang Zhao, XuDong Qu, ZhiPing Yan, FuYou Li, LingXiao Liu Source Type: research
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers
CONCLUSION: The use of advanced BT approach in reirradiation setting is a feasible and safe option in treatment of post-treatment recurrent cervical, endometrial, and vaginal cancers.PMID:37716821 | DOI:10.1016/j.brachy.2023.07.004
Source: Cancer Control - September 16, 2023 Category: Cancer & Oncology Authors: Umesh Mahantshetty Sheetal R Kashid Gargee Mulye Lavanya Gurram Reena Engineer Supriya Chopra Jaya Ghosh Seema Gulia Sudeep Gupta Yogesh Ghadi Dheera A Satish Kohle Sudarshan Kadam Santosh Menon Kedar Deodhar Amita Maheswari Shylasree T S Shirley Lewis Ni Source Type: research
Clinical implementation of 3D transvaginal ultrasound for intraoperative guidance of needle implant in template interstitial gynecologic high-dose-rate brachytherapy
To demonstrate novel clinical implementation of a 3D transvaginal ultrasound (3DTVUS) system for intraoperative needle insertion guidance in perineal template interstitial gynecologic high-dose-rate brachytherapy and assess its impact on implant quality.
Source: Brachytherapy - September 16, 2023 Category: Cancer & Oncology Authors: Devin Van Elburg, Tyler Meyer, Kevin Martell, Sarah Quirk, Robyn Banerjee, Tien Phan, Aaron Fenster, Michael Roumeliotis Source Type: research
Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience
This study evaluates the outcomes of recurrent brain metastasis treated with resection and brachytherapy using a novel Cesium-131 carrier, termed surgically targeted radiation therapy (STaRT), and compares them to the first course of external beam radiotherapy (EBRT).
Source: Brachytherapy - September 16, 2023 Category: Cancer & Oncology Authors: Tugce Kutuk, Ranjini Tolakanahalli, Vibha Chaswal, Sreenija Yarlagadda, Roberto Herrera, Haley Appel, Alonso La Rosa, Vivek Mishra, D.Jay J. Wieczorek, Michael W. McDermott, Vitaly Siomin, Minesh P. Mehta, Yazmin Odia, Alonso N. Gutierrez, Rupesh Kotecha Source Type: research
Utilizing a novel hybrid brachytherapy technique FINITO (Freehand Interstitial Needles in addition to Tandem and Ovoid) for locally advanced cervical cancer
We aimed to assess the clinical feasibility and advantages of using a novel hybrid brachytherapy technique by placing Freehand Interstitial Needles in addition to the Tandem and Ovoid applicator (FINITO) for the treatment of locally advanced cervical cancer (LAC).
Source: Brachytherapy - September 16, 2023 Category: Cancer & Oncology Authors: Yue H. Zhang, Sara Martin, Han Liu, Dorin Todor, James J. Sohn, Bridget Quinn, Louise.E. Francis, Melinda Roach, Emma C. Fields Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Spindle-cell myoepithelioma: a rare case in a finger of a 15-year-old boy
We report the case of a 15 year-old boy affected by a rare form of locally aggressive spindle-cell myoepithelioma, and suggest a new multidisciplinary approach combining surgical excision and custom brachytherapy.PMID:37714516 | DOI:10.1016/j.hansur.2023.09.001
Source: Hand Surgery - September 15, 2023 Category: Surgery Authors: S Pietramala A Tulli G Merendi C Fulchignoni M Quirino N Di Napoli L Tagliaferri A Pagliei Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Spindle-cell myoepithelioma: a rare case in a finger of a 15-year-old boy
We report the case of a 15 year-old boy affected by a rare form of locally aggressive spindle-cell myoepithelioma, and suggest a new multidisciplinary approach combining surgical excision and custom brachytherapy.PMID:37714516 | DOI:10.1016/j.hansur.2023.09.001
Source: Hand Surgery - September 15, 2023 Category: Surgery Authors: S Pietramala A Tulli G Merendi C Fulchignoni M Quirino N Di Napoli L Tagliaferri A Pagliei Source Type: research
Novel intraocular shielding device for eye plaque brachytherapy using magnetite nanoparticles: A proof-of-concept study using radiochromic film and Monte Carlo simulations
Eye plaque brachytherapy is a mainstay treatment for uveal melanomas despite potential toxicities to normal tissues. This work proposes a nanoparticle ferrofluid as a novel intraocular shielding device. With a modified magnetic plaque, the shielding particles are drawn to the tumor surface, attenuating dose beyond the tumor while maintaining prescription dose to the target.
Source: Brachytherapy - September 15, 2023 Category: Cancer & Oncology Authors: Courtney C. Oare, James P. Dailey, Bruce Gerbi, Clara Ferreira Source Type: research
Monte Carlo dosimetry of a novel Yttrium-90 disc source for episcleral brachytherapy
CONCLUSION: Monte Carlo simulations were successfully performed to confirm the measured PDD curve of the novel Y-90 disc source. This simulation work laid a solid foundation for characterizing the full dosimetry parameters of this source for episcleral brachytherapy applications.PMID:37708092 | DOI:10.1002/acm2.14140
Source: Health Physics - September 14, 2023 Category: Physics Authors: Xiangyun Chang Lyu Huang Jian Liu Yijian Cao Jenghwa Chang Source Type: research
